Offermann, A., & Duensing, S. (2017). MED15 overexpression in prostate cancer arises during androgen deprivation therapy via PI3K/mTOR signaling. OncoTarget, 8(5), . https://doi.org/10.18632/oncotarget.13860
Chicago Style (17th ed.) CitationOffermann, Anne, and Stefan Duensing. "MED15 Overexpression in Prostate Cancer Arises During Androgen Deprivation Therapy via PI3K/mTOR Signaling." OncoTarget 8, no. 5 (2017). https://doi.org/10.18632/oncotarget.13860.
MLA (9th ed.) CitationOffermann, Anne, and Stefan Duensing. "MED15 Overexpression in Prostate Cancer Arises During Androgen Deprivation Therapy via PI3K/mTOR Signaling." OncoTarget, vol. 8, no. 5, 2017, https://doi.org/10.18632/oncotarget.13860.
Warning: These citations may not always be 100% accurate.